Clin Osteol 2017; 22(1): 3-8

Prediction of asymptomatic vertebral fractures by selected clinical risk factorsOriginal contributions

Z. Killinger, D. Čierny, P. Jackuliak, M. Kužma, J. Payer

Published: June 11, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Killinger Z, Čierny D, Jackuliak P, Kužma M, Payer J. Prediction of asymptomatic vertebral fractures by selected clinical risk factors. Osteologický bulletin. 2017;22(1):3-8.
Download citation

References

  1. Ivergárd M, Svedbom A, Hernlund E, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Masaryk P, Payer J, Jackuliak P, Kanis JA. Epidemiology and Economic Burden of Osteoporosis in Slovakia. A report prepared in collaboration with the Internat Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 2013;8(137):178-186.
  2. Melton III LJ, Kan SH, Frye MA, Wahner HW, O'Fallon WM, Riggs BL. Epidemiology of vertebral fractures in women. Am J Epidemiol 1989;129:1000-1011. Go to original source...
  3. Guermazi A, Mohr A, Grigorian M, Taouli B, Genant HK. Iden­ tification of vertebral fractures in osteoporosis. Semin Musculoske Radiol 2002;6:241-252. Go to original source...
  4. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2013;24:23-57. Go to original source...
  5. Watts NB, Lewiecki EM, Miller PD, Baim S. National Osteoporosis Foundation 2008 Clinician's Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist. J Clin Densitom 2008;11(4):473-477. Go to original source...
  6. Van Brussel MS, Lems WF. Clinical relevance of diagnosing vertebral fractures by vertebral fracture assessment. Curr Osteoporos Rep 7(3):103-106.
  7. Delmas PD, van de Langerijt L, Watts NB, Eastell R, Genant H, Grauer A, Cahall DL. Underdiagnosis of vertebral fractures is a w wide problem: the IMPACT study. J Bone Miner Res 2005; 20:557-563. Go to original source...
  8. Grados F, Fechtenbaum J, Flipon E, Kolta S, Roux C, Fardellone P. Radiographic methods for evaluating osteoporotic vertebral fra res. Joint Bone Spine 2009;76(3):241-247. Go to original source...
  9. Green AD, Colón-Emeric CS, Bastian L, Drake MT, Lyles KW. Does this woman have osteoporosis? JAMA 2004;292(23):2890-2900. Go to original source...
  10. Payer J, Brazdilova K, Jackuliak P. Management of glucocorticoid duced osteoporosis: prevalence, and emerging treatment options. Drug Health Patient Saf2010;2:49-59. Go to original source...
  11. Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D. Risk of mor­ tality following clinical fractures. Osteoporos Int 2000;11:556-561. Go to original source...
  12. Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB et al. Risk of new vertebral fracture in the year following a fra JAMA 2001;258(3):320-323. Go to original source...
  13. Green AD, Colón-Emeric CS, Bastian L Drake MT, Lyles KW. Does this woman have osteoporosis? JAMA 2004;292(23):2890-2900. Go to original source...
  14. Netelenbos JC, Lems WF, Geusens PP, Verhaar HJ, Boermans AJM, Boomsma MM et al. Spine radiographs to improve the identification of women at high risk for fractures. Osteoporos Int 2009; 20:1347-1352. Go to original source...
  15. Chen P, Krege JH, Adachi JD, Prior JC, Tenenhouse A, Brown JP et al. Vertebral fracture status and the World Health Organization risk fac for predicting osteoporotic fracture risk. J Bone Miner Res 2009;24: 495-502. Go to original source...
  16. Ensrud KE, Lui LY, Taylor BC, Schousboe JT, Donaldson MG, Fink HA et al. A comparison of prediction models for fractures in older wo­ men: is more better? Study of Osteoporo Arch Intern Med 2009;169(22):2087-2094. Go to original source...




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.